BWAY

Brainsway

10.27 USD
+0.46
4.69%
At close May 14, 4:00 PM EDT
1 day
4.69%
5 days
15.65%
1 month
23.44%
3 months
-9.12%
6 months
7.76%
Year to date
7.20%
1 year
87.41%
5 years
28.54%
10 years
-7.39%
 

About: BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Employees: 120

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

84% more capital invested

Capital invested by funds: $30.2M [Q3] → $55.6M (+$25.3M) [Q4]

19% more funds holding

Funds holding: 32 [Q3] → 38 (+6) [Q4]

5.85% more ownership

Funds ownership: 9.81% [Q3] → 15.65% (+5.85%) [Q4]

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$16
56%
upside
Avg. target
$16
56%
upside
High target
$16
56%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Raghuram Selvaraju
38% 1-year accuracy
117 / 309 met price target
56%upside
$16
Buy
Reiterated
12 Mar 2025

Financial journalist opinion

Neutral
Seeking Alpha
1 day ago
BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Brian Ritchie – LifeSci Advisors LLC Hadar Levy – Chief Executive Officer Ido Marom – Chief Financial Officer Conference Call Participants Steve Lichtman – Oppenheimer & Company Operator Good day, and welcome to the BrainsWay First Quarter 2025 Earnings Conference Call.
BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
1 day ago
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
Achieved r ecord quarterly s ales of $11. 5 million in Q 1 202 5 , an increase of 27% compared to Q 1 202 4
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
Neutral
Seeking Alpha
2 months ago
BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffrey S.
BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
2 months ago
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Achieved r ecord quarterly s ales of $11.4 million in Q4 2024 , an increase of 27% compared with Q4 2023
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Negative
Zacks Investment Research
2 months ago
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings?
BrainsWay  BWAY shares plunged 15.7% in the past four trading sessions, falling below the 50-day moving average, implying weakness in the stock. Meanwhile, BWAY is scheduled to release its fourth-quarter results on March 11.
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings?
Positive
Zacks Investment Research
2 months ago
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
Positive
Zacks Investment Research
2 months ago
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Positive
Zacks Investment Research
2 months ago
5 Stocks With Recent Price Strength to Enhance Your Portfolio
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SBFG, FCCO, SNEX, BYRN, BWAY.
5 Stocks With Recent Price Strength to Enhance Your Portfolio
Positive
Zacks Investment Research
3 months ago
4 Top-Ranked Solid Net Profit Margin Stocks to Boost Portfolio Returns
Let us take a look at four top-ranked stocks, AVO, ACEL, BWAY and FRBA, with stellar net profit margins that can help create a winning portfolio.
4 Top-Ranked Solid Net Profit Margin Stocks to Boost Portfolio Returns
Positive
Zacks Investment Research
3 months ago
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY
Bridgewater Bancshares, Eastern Bankshares and BrainsWay have been selected as the breakout stocks for today.
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY
Charts implemented using Lightweight Charts™